GIP
ELV icon

Greatmark Investment Partners’s Elevance Health ELV Stock Holding History

Greatmark Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Buy
38,622
+1,845
+5% +$606K 1.32% 23
2025
Q4 		$12.9M Buy
36,777
+1,294
+4% +$437K 1.52% 22
2025
Q3 		$11.5M Buy
35,483
+6,833
+24% +$2.13M 1.37% 24
2025
Q2 		$11.1M Buy
28,650
+2,568
+10% +$1.03M 1.4% 24
2025
Q1 		$11.3M Buy
26,082
+2,154
+9% +$865K 1.55% 24
2024
Q4 		$8.83M Buy
23,928
+4,678
+24% +$1.96M 1.2% 26
2024
Q3 		$10M Buy
19,250
+181
+0.9% +$96.7K 1.36% 26
2024
Q2 		$10.3M Buy
19,069
+264
+1% +$140K 1.51% 26
2024
Q1 		$9.75M Buy
18,805
+315
+2% +$157K 1.39% 26
2023
Q4 		$8.72M Buy
18,490
+1,416
+8% +$655K 1.37% 26
2023
Q3 		$7.43M Buy
17,074
+90
+0.5% +$40.8K 1.31% 27
2023
Q2 		$7.55M Sell
16,984
-376
-2% -$173K 1.27% 27
2023
Q1 		$7.98M Sell
17,360
-12
-0.1% -$5.71K 1.42% 25
2022
Q4 		$8.91M Sell
17,372
-393
-2% -$200K 1.63% 23
2022
Q3 		$8.07M Sell
17,765
-5
-0% -$2.39K 1.56% 24
2022
Q2 		$8.57M Sell
17,770
-669
-4% -$331K 1.65% 21
2022
Q1 		$9.06M Sell
18,439
-75
-0.4% -$34.3K 1.49% 24
2021
Q4 		$8.58M Sell
18,514
-67
-0.4% -$28.2K 1.44% 25
2021
Q3 		$6.93M Sell
18,581
-245
-1% -$93.1K 1.3% 27
2021
Q2 		$7.19M Sell
18,826
-425
-2% -$162K 1.3% 28
2021
Q1 		$6.91M Sell
19,251
-518
-3% -$167K 1.35% 26
2020
Q4 		$6.35M Sell
19,769
-40
-0.2% -$12.3K 1.37% 26
2020
Q3 		$5.32M Buy
19,809
+930
+5% +$250K 1.34% 27
2020
Q2 		$4.96M Sell
18,879
-350
-2% -$93.4K 1.31% 27
2020
Q1 		$4.37M Buy
19,229
+655
+4% +$178K 1.4% 23
2019
Q4 		$5.61M Buy
18,574
+1,490
+9% +$410K 1.39% 26
2019
Q3 		$4.1M Buy
17,084
+2,215
+15% +$607K 1.12% 29
2019
Q2 		$4.2M Buy
14,869
+126
+0.9% +$34.4K 1.25% 26
2019
Q1 		$4.23M Sell
14,743
-404
-3% -$117K 1.33% 25
2018
Q4 		$3.98M Sell
15,147
-875
-5% -$241K 1.43% 23
2018
Q3 		$4.39M Sell
16,022
-15
-0.1% -$3.89K 1.38% 27
2018
Q2 		$3.82M Sell
16,037
-268
-2% -$62.1K 1.32% 28
2018
Q1 		$3.58M Sell
16,305
-547
-3% -$128K 1.31% 27
2017
Q4 		$3.79M Sell
16,852
-1,387
-8% -$295K 1.37% 25
2017
Q3 		$3.46M Sell
18,239
-710
-4% -$135K 1.33% 27
2017
Q2 		$3.56M Sell
18,949
-399
-2% -$71.7K 1.43% 24
2017
Q1 		$3.2M Buy
19,348
+425
+2% +$67.6K 1.32% 25
2016
Q4 		$2.72M Sell
18,923
-965
-5% -$129K 1.14% 27
2016
Q3 		$2.49M Sell
19,888
-302
-1% -$39K 1.08% 27
2016
Q2 		$2.65M Sell
20,190
-1,398
-6% -$191K 1.18% 28
2016
Q1 		$3M Sell
21,588
-2,320
-10% -$310K 1.36% 24
2015
Q4 		$3.33M Buy
23,908
+210
+0.9% +$28.9K 1.46% 23
2015
Q3 		$3.32M Sell
23,698
-850
-3% -$128K 1.53% 21
2015
Q2 		$4.03M Buy
24,548
+225
+0.9% +$35.9K 1.72% 20
2015
Q1 		$3.76M Buy
24,323
+270
+1% +$38.4K 1.61% 20
2014
Q4 		$3.02M Buy
24,053
+3,050
+15% +$377K 1.29% 27
2014
Q3 		$2.51M Buy
21,003
+350
+2% +$40.1K 1.17% 30
2014
Q2 		$2.22M Buy
20,653
+1,370
+7% +$141K 0.93% 34
2014
Q1 		$1.92M Buy
19,283
+4,355
+29% +$394K 0.86% 37
2013
Q4 		$1.38M Buy
14,928
+1,425
+11% +$127K 0.65% 42
2013
Q3 		$1.13M Buy
13,503
+575
+4% +$49.3K 0.59% 46
2013
Q2 		$1.06M Buy
+12,928
New +$968K 0.68% 43

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Greatmark Investment Partners's ELV Position: Q1 2026 in Review

Greatmark Investment Partners increased its Elevance Health (ELV) stake by 5% in Q1 2026, buying an estimated $606K and bringing the position to 38,622 shares worth $11.3M. The position accounts for 1.32% of the portfolio, ranked #23.

Greatmark Investment Partners first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.9M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Greatmark Investment Partners held 38,622 shares of Elevance Health worth $11.3M as of Q1 2026.
  • Greatmark Investment Partners bought 1,845 Elevance Health shares in Q1 2026, an estimated $606K.
  • Elevance Health made up 1.32% of Greatmark Investment Partners's portfolio in Q1 2026, its #23 holding.
  • Greatmark Investment Partners first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Greatmark Investment Partners's Elevance Health position peaked at $12.9M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Greatmark Investment Partners's 13F filing for Q1 2026, filed 28 Apr 2026.